The results demonstrated that the overall survival of patients with numerous DEGs (HIST1H3J, HIST1H2BD, HIST1H4K, HIST1H2AD, HIST1H2BH, HIST1H2BO, HIST1H2BL, HIST1H2BJ, HIST1H4E, HIST1H3C, HIST1H3D, HIST1H2AJ, HIST1H2AM, HIST3H2BB, HIST1H3F and HIST1H2AL) in the SLE pathway was significantly improved compared to those with fewer DEGs in the SLE pathway (p = 0.02104). This evidence concerns the gene H2BC11 and systemic lupus erythematosus.